ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,235,000 | +7693.8% | 134,582 | +4001.9% | 0.12% | +3733.3% |
| Q1 2019 | $80,000 | -77.7% | 3,281 | -86.9% | 0.00% | -82.4% |
| Q4 2018 | $358,000 | -83.5% | 25,141 | -80.6% | 0.02% | -84.4% |
| Q2 2018 | $2,172,000 | +209.8% | 129,461 | +201.5% | 0.11% | +165.9% |
| Q1 2018 | $701,000 | +4023.5% | 42,932 | +3125.5% | 0.04% | +4000.0% |
| Q4 2017 | $17,000 | -89.1% | 1,331 | -89.5% | 0.00% | -88.9% |
| Q3 2017 | $156,000 | -71.7% | 12,647 | -80.8% | 0.01% | -74.3% |
| Q2 2017 | $551,000 | +257.8% | 65,807 | +281.2% | 0.04% | +218.2% |
| Q1 2017 | $154,000 | +294.9% | 17,265 | +292.4% | 0.01% | +266.7% |
| Q4 2016 | $39,000 | +14.7% | 4,400 | -61.8% | 0.00% | +50.0% |
| Q1 2016 | $34,000 | -88.2% | 11,531 | -81.7% | 0.00% | -86.7% |
| Q3 2015 | $287,000 | +165.7% | 63,035 | +321.6% | 0.02% | +200.0% |
| Q2 2015 | $108,000 | – | 14,952 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |